Cargando…

Impact of non-cardiovascular comorbidities on the quality of life of patients with chronic heart failure: a scoping review

PURPOSE: To determine the impact of non-cardiovascular comorbidities on the health-related quality of life (HRQoL) of patients with chronic heart failure (CHF). METHODS: A scoping review of the scientific literature published between 2009 and 2019 was carried out. Observational studies which assesse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Comín-Colet, Josep, Martín Lorenzo, Teresa, González-Domínguez, Almudena, Oliva, Juan, Jiménez Merino, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542693/ https://www.ncbi.nlm.nih.gov/pubmed/33028351 http://dx.doi.org/10.1186/s12955-020-01566-y

Ejemplares similares

Iron deficiency in chronic heart failure: case‐based practical guidance
por: Lam, Carolyn S. P., et al.
Publicado: (2018)

Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity?
por: Moliner, Pedro, et al.
Publicado: (2019)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

The Future of Telemedicine in the Management of Heart Failure Patients
por: Silva-Cardoso, José, et al.
Publicado: (2021)

Iron Deficiency: Impact on Functional Capacity and Quality of Life in Heart Failure with Preserved Ejection Fraction
por: Alcaide-Aldeano, Alex, et al.
Publicado: (2020)

Use of potassium-binder patiromer for up-titration of renin–angiotensin–aldosterone system inhibition therapy in a patient with chronic heart failure and reduced ejection fraction followed in a multidisciplinary integrated chronic care management programme: a case report
por: Jiménez-Marrero, Santiago, et al.
Publicado: (2020)

Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status
por: Comín-Colet, Josep, et al.
Publicado: (2013)

Psychosocial factors partially explain gender differences in health‐related quality of life in heart failure patients
por: Tapia, Javier, et al.
Publicado: (2022)

Clinical practices and attitudes regarding the diagnosis and management of heart failure: findings from the CORE Needs Assessment Survey
por: Howlett, Jonathan, et al.
Publicado: (2017)

Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
por: González-Juanatey, José Ramón, et al.
Publicado: (2023)

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study
por: Comin-Colet, Josep, et al.
Publicado: (2013)

Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction
por: Gastelurrutia, Paloma, et al.
Publicado: (2018)

Gender Differences in Health-Related Quality of Life in Patients with Systolic Heart Failure: Results of the VIDA Multicenter Study
por: Garay, Alberto, et al.
Publicado: (2020)

Prognostic Value of the Acute-to-Chronic Glycemic Ratio at Admission in Heart Failure: A Prospective Study
por: Carrera, Mª José, et al.
Publicado: (2021)

Ischemic aetiology, self-reported frailty, and gender with respect to cognitive impairment in chronic heart failure patients
por: González-Moneo, María J, et al.
Publicado: (2016)

Quality of life and disease experience in patients with heart failure with reduced ejection fraction in Spain: a mixed-methods study
por: Rubio, Raül, et al.
Publicado: (2021)

Blood Differential Gene Expression in Patients with Chronic Heart Failure and Systemic Iron Deficiency: Pathways Involved in Pathophysiology and Impact on Clinical Outcomes
por: Díez-López, Carles, et al.
Publicado: (2021)

Importance of iron deficiency in patients with chronic heart failure as a predictor of mortality and hospitalizations: insights from an observational cohort study
por: González-Costello, José, et al.
Publicado: (2018)

Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial
por: Kosiborod, Mikhail N., et al.
Publicado: (2022)

Real world heart failure epidemiology and outcome: A population-based analysis of 88,195 patients
por: Farré, Núria, et al.
Publicado: (2017)

Practical Guidance for Diagnosing and Treating Iron Deficiency in Patients with Heart Failure: Why, Who and How?
por: Sindone, Andrew, et al.
Publicado: (2022)

Systematic review and meta‐analysis of intravenous iron‐carbohydrate complexes in HFrEF patients with iron deficiency
por: Sindone, Andrew, et al.
Publicado: (2022)

Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice
por: McDonagh, Theresa, et al.
Publicado: (2018)

The social return on investment of a new approach to heart failure in the Spanish National Health System
por: Merino, María, et al.
Publicado: (2020)

Association of heart failure and its comorbidities with loss of life expectancy
por: Drozd, Michael, et al.
Publicado: (2021)

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period
por: Pölzl, Gerhard, et al.
Publicado: (2018)

Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
por: Farré, Nuria, et al.
Publicado: (2017)

Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction
por: Cristóbal, Helena, et al.
Publicado: (2023)

Síndrome de tako-tsubo asociado con COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tako-tsubo syndrome associated with COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020)

Tratamiento neurohormonal en miocardiopatía de tako-tsubo precipitada por COVID-19. Respuesta
por: Oyarzabal, Loreto, et al.
Publicado: (2021)

Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19. Response
por: Oyarzabal, Loreto, et al.
Publicado: (2021)

Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS)
por: Yun, Sergi, et al.
Publicado: (2020)

Self-Care and Quality of Life Among Adult Patients With Heart Failure: Scoping Review
por: Seid, Sheka Shemsi, et al.
Publicado: (2023)

Cardiac Imaging in Heart Failure with Comorbidities
por: Wong, Chiew, et al.
Publicado: (2017)

Performance of Three Measures of Comorbidity in Predicting Critical COVID-19: A Retrospective Analysis of 4607 Hospitalized Patients
por: Monterde, David, et al.
Publicado: (2021)

Soluble Transferrin Receptor as Iron Deficiency Biomarker: Impact on Exercise Capacity in Heart Failure Patients
por: Ras-Jiménez, Maria del Mar, et al.
Publicado: (2023)

Real-World Epidemiology of Potassium Derangements Among Chronic Cardiovascular, Metabolic and Renal Conditions: A Population-Based Analysis
por: Jiménez-Marrero, Santiago, et al.
Publicado: (2020)

Effects of Cardiac Rehabilitation on Sleep Quality in Heart Disease Patients with and without Heart Failure
por: Lodi Rizzini, Fabio, et al.
Publicado: (2022)

Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol
por: Oyanguren, Juana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o5608gkc60gma70l6kd8an50mh